The production of oxygen isotope O-18 used in early-stage cancer diagnostics will soon start in Roshino settlement. “Oksimed Ltd.” will perform the production with an investment volume of $2 million.
This kind of isotope is used in early-stage cancer diagnostics on positron-emission tomographs (PET). “Oksimed Ltd.” was specially established to carry out the project. “Upravlyaushaya Companya (Management Company) “RosPoliTehGruppa Ltd.”” owns 49% of its shares, while 51% of the package belongs to the Moscow company “TehSnabEksport”.
News source: www.dp.ru
Print this news
Business news archive for 08 January' 2004.
Business news archive for January' 2004.
Business news archive for 2004 year.